Detalhe da pesquisa
1.
Divergent low-density lipoprotein receptor (LDLR) linked to low VSV G-dependent viral infectivity and unique serum lipid profile in zebra finches.
Proc Natl Acad Sci U S A
; 118(18)2021 05 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33903244
2.
Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis-Brief Report.
Arterioscler Thromb Vasc Biol
; 42(1): e1-e9, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34758632
3.
Insights into the kinetics and dynamics of the furin-cleaved form of PCSK9.
J Lipid Res
; 62: 100003, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33429337
4.
PMP22 Regulates Cholesterol Trafficking and ABCA1-Mediated Cholesterol Efflux.
J Neurosci
; 39(27): 5404-5418, 2019 07 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31061090
5.
Subcellular diversion of cholesterol by gain- and loss-of-function mutations in PMP22.
Glia
; 68(11): 2300-2315, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32511821
6.
PCSK9: From Basic Science Discoveries to Clinical Trials.
Circ Res
; 122(10): 1420-1438, 2018 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29748367
7.
Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.
Circulation
; 138(17): 1850-1863, 2018 10 23.
Artigo
Inglês
| MEDLINE | ID: mdl-29794082
8.
PCSK9 Association With Lipoprotein(a).
Circ Res
; 119(1): 29-35, 2016 06 24.
Artigo
Inglês
| MEDLINE | ID: mdl-27121620
9.
Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
Arterioscler Thromb Vasc Biol
; 36(8): 1483-95, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27365402
10.
Local effects of human PCSK9 on the atherosclerotic lesion.
J Pathol
; 238(1): 52-62, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26333678
11.
PMP22 is critical for actin-mediated cellular functions and for establishing lipid rafts.
J Neurosci
; 34(48): 16140-52, 2014 Nov 26.
Artigo
Inglês
| MEDLINE | ID: mdl-25429154
12.
Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL.
J Lipid Res
; 56(3): 635-643, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25593328
13.
Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms.
Circulation
; 130(5): 431-41, 2014 Jul 29.
Artigo
Inglês
| MEDLINE | ID: mdl-25070550
14.
Response by Mueller et al to Letter Regarding Article, "Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages".
Circulation
; 139(16): 1983-1984, 2019 04 16.
Artigo
Inglês
| MEDLINE | ID: mdl-30986111
15.
Targeting PCSK9 for therapeutic gains.
Curr Atheroscler Rep
; 17(4): 499, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25712137
16.
Loss of plasma proprotein convertase subtilisin/kexin 9 (PCSK9) after lipoprotein apheresis.
Circ Res
; 113(12): 1290-5, 2013 Dec 06.
Artigo
Inglês
| MEDLINE | ID: mdl-24122718
17.
Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice.
J Lipid Res
; 55(10): 2073-81, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25183802
18.
Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.
Circulation
; 127(24): 2403-13, 2013 Jun 18.
Artigo
Inglês
| MEDLINE | ID: mdl-23690465
19.
Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor.
Ann Intern Med
; 168(5): 376-379, 2018 03 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29181527
20.
Effect of PCSK9 inhibition on plasma levels of small dense low density lipoprotein-cholesterol and 7-ketocholesterol.
J Clin Lipidol
; 18(1): e50-e58, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-37923663